Neos Therapeutics (NEOS) Tops Q4 EPS by 9c

Neos Therapeutics (NASDAQ: NEOS) reported Q4 EPS of ($0.57), $0.09 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $1.7 million, versus $500 thousand reported last year.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79